The recent firing of former Centers for Disease Control and Prevention director Susan Monarez and the subsequent resignation of four of the agency’s top career officials marks a major offensive by Health and Human Services Secretary Robert F. Kennedy Jr. to seize control of the agency and impose an anti-vaccine, anti-science agenda that will have…
Mental health company Lyra Health is now offering services for people struggling with cannabis, stimulants, opioids and nicotine. The post Lyra Health Expands Substance Use Disorder Support appeared first on MedCity News.
Health payers created the prior authorization system as a cost and quality control strategy, ensuring patients receive only the most necessary, evidence-based, cost-effective and quality care. Nevertheless, real-life implementation has shown that prior authorizations often backfire on their original intents, increasing overall care costs beyond what is necessary. It also delays patient care, contributes to…
Following Brexit, the funding infrastructure for new buyout funds in the UK has broken down. These new managers are now struggling to find anchor investors and offer an opportunity to the private sector to step in and secure attractive returns. The post The Opportunity being Missed in UK Healthcare Buyouts appeared first on MedCity News.
Check out news from Oral Genome, DataJoint, Health Wildcatters, and more. The post StartUPDATES: New Developments for Healthcare Startups appeared first on MedCity News.
There were gains in coverage across most racial and ethnic groups between 2019 and 2023 after several years of rising uninsured rates during the first Trump administration. The coverage gains between 2019 and 2023 were largely driven by increases in Medicaid coverage, reflecting policies to stabilize and expand access to affordable coverage that were implemented…
The FDA will provide faster regulatory review of generic drugs that are tested in and manufactured in the U.S. using domestically sourced active pharmaceutical ingredients. This FDA pilot program is part of a broader Trump administration strategy to reshore pharmaceutical production. The post FDA Pilot Program Creates New Path for Faster Regulatory Review of Generic…
The ‘Sutter Sync’ devices will support patients managing Type 2 diabetes, high blood pressure and those who are pregnant
Despite improvements, the U.S. still exhibits higher maternal mortality rates than most high-income countries, with significant racial disparities
Harbor Health’s funding was co-led by General Catalyst, 8VC and Alta Partners. The round also includes participation from Dell Family Office Management, Health 2047 Capital Partners, Lemhi Ventures, Martin Ventures and Breyer Capital. The post Harbor Health Secures $130M To Grow Insurance Plans and Clinical Footprint appeared first on MedCity News.